CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
A Decrease in the Dose of Pegvisomant was Needed for the Treatment of Acromegaly after Adrenalectomy in a Patient with Coexisting Preclinical Cushing's Syndrome
Authors
Ji S, Messina JL Bennett WL
Mallo F, Señ Dieguez C
+19Â more
Becker CE, Levey GS, Roth Gorden P
Chung TT, Lawrance J, Dr Higham CE
Kemp SF, Hintz RL Horner JM
Findell PR, Mellon P, Wi Isaacs RE
Reyes CM, Sundeen RE, Fred Jehle S
Cuttler L Korytko AI
McKeel DW Jr, Buckley Leveston SA
Mü
Reed CE, Murray RH, R McCormick RV
Akikawa K, Matsubara M, Nakagawa K
Aron D Nawar R
de Herder WW, Janssen J Neggers SJ
Lawrence DA, Vogel D Rosenzweig JL
Becker M, Soetadji S Rosskamp R
Kamegai J, Sugihara H, Ki Tamura H
Baxter RC Tan K
Karavitaki N, Stylianido Tzanala M
Tatsuno I, Nakamura S, et Uchida D
Kudo K, Okushima T, Nak Watanobe H
Publication date
1 January 2011
Publisher
'Japanese Society of Internal Medicine'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 22/11/2020